Home Canadian DIN search IOTHALAMATE MEGLUMINE DIN 00131237
CONRAY 60 DIN 00131237
Status: Cancelled Post Market
Holder: LIEBEL-FLARSHEIM COMPANY LLC
Health Canada record
Active ingredient(s) IOTHALAMATE MEGLUMINE 600 MG Dosage form Solution Route Intravascular Schedule ETHICAL Class Human ATC V08AA04 IOTALAMIC ACID Original market date 31-Dec-1951 Current status date 26-May-2026 Source Health Canada DPD
Establishment licence of the holder Liebel-Flarsheim Canada Inc. — licence 102249, not currently licensed, last inspection rating C (2023-11-06).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing IOTHALAMATE MEGLUMINE DIN Product Company Form Strength Status 00223107 CONRAY 30 LIEBEL-FLARSHEIM CANADA INC Solution IOTHALAMATE MEGLUMINE 300 MG Cancelled Post Market 00477095 CONRAY 43 LIEBEL-FLARSHEIM CANADA INC Solution IOTHALAMATE MEGLUMINE 430 MG Cancelled Post Market 00274194 CYSTO CONRAY INJ 43% MALLINCKRODT CANADA INC. Liquid IOTHALAMATE MEGLUMINE 430 MG Cancelled Post Market 00397466 CYSTO-CONRAY II LIEBEL-FLARSHEIM COMPANY LLC Solution IOTHALAMATE MEGLUMINE 172 MG Cancelled Post Market 00131628 VASCORAY TYCO HEALTHCARE Solution IOTHALAMATE MEGLUMINE 520 MG; IOTHALAMATE SODIUM 260 MG Cancelled Post Market
Notices of Compliance NOC Date Submission Reason 28833 2022-08-24 New Drug Submission (NDS) Administrative: Change in Product Ownership
Removal of CONRAY 30 and CONRAY 43 from the Product
Monograph (PM) and to update the PM to the 2020 Master
Template 16521 2015-01-13 New Drug Submission (NDS) TRANSFER OF DRUG IDENTIFICATION NUMBERS 13918 2012-11-30 New Drug Submission (NDS) Manufacturer name change 676 2002-07-02 New Drug Submission (NDS) MANUFACTURER NAME CHANGE
Request a quote for CONRAY 60
How to read a Canadian DIN record